Royal Bank of Canada’s BriaCell Therapeutics Corp Warrant BCTXW Stock Holding History

Royal Bank of Canada’s Portfolio BCTXW Stock Details BCTXW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-225	Closed	–	–	7112
2025 Q4	$0	Buy	+225	New	+$11	﹤0.01%	7160

Royal Bank of Canada's BCTXW Position: Q1 2026 in Review

Royal Bank of Canada sold out of BriaCell Therapeutics Corp Warrant (BCTXW) in Q1 2026, closing a stake of 225 shares.

Royal Bank of Canada first reported a position in BCTXW in Q4 2025 and held it in 1 quarter. The position peaked at $0 in Q4 2025. 0 funds tracked by Wall St. Rank hold BCTXW as of Q1 2026.

Royal Bank of Canada reported no remaining BriaCell Therapeutics Corp Warrant position as of Q1 2026 after selling out during the quarter.
Royal Bank of Canada sold 225 BriaCell Therapeutics Corp Warrant shares in Q1 2026.
Royal Bank of Canada first reported a position in BriaCell Therapeutics Corp Warrant in Q4 2025 and held it in 1 quarter.
Royal Bank of Canada's BriaCell Therapeutics Corp Warrant position peaked at $0 in Q4 2025.
0 funds tracked by Wall St. Rank held BriaCell Therapeutics Corp Warrant as of Q1 2026.

Based on Royal Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.